Exane Derivatives Albemarle Corp Transaction History

Exane Derivatives

$157 Million
Q2 2022

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$187.76 - $270.92 $176,869 - $255,206	-942 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$172.09 - $246.0 $151,611 - $216,726	-881 Reduced 48.33%	942 $208,000
Q4 2021 Jan 28, 2022	SELL	$214.16 - $283.8 $165,117 - $218,809	-771 Reduced 29.72%	1,823 $426,000
Q3 2021 Oct 26, 2021	SELL	$167.91 - $244.03 $4,701 - $6,832	-28 Reduced 1.07%	2,594 $568,000
Q2 2021 Jul 28, 2021	BUY	$143.7 - $176.01 $376,781 - $461,498	2,622 New	2,622 $441,000
Q1 2021 Apr 30, 2021	SELL	$140.69 - $185.25 $377,752 - $497,396	-2,685 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$86.73 - $149.91 $48,221 - $83,349	556 Added 26.12%	2,685 $396,000
Q3 2020 Oct 06, 2020	SELL	$75.75 - $100.45 $23,103 - $30,637	-305 Reduced 12.53%	2,129 $190,000
Q2 2020 Jul 10, 2020	BUY	$52.7 - $86.74 $85,374 - $140,518	1,620 Added 199.02%	2,434 $187,000
Q1 2020 Apr 17, 2020	BUY	$50.9 - $94.31 $23,973 - $44,420	471 Added 137.32%	814 $45,000
Q4 2019 Jan 22, 2020	SELL	$60.74 - $73.04 $6,802 - $8,180	-112 Reduced 24.62%	343 $25,000
Q2 2019 Jul 12, 2019	BUY	$63.3 - $86.94 $28,801 - $39,557	455 New	455 $0
Q1 2019 Apr 24, 2019	SELL	$72.69 - $92.28 $958,344 - $1.22 Million	-13,184 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$73.13 - $107.99 $587,087 - $866,943	8,028 Added 155.7%	13,184 $1.02 Million
Q3 2018 Oct 24, 2018	SELL	$90.9 - $106.6 $55,176 - $64,706	-607 Reduced 10.53%	5,156 $0
Q2 2018 Oct 24, 2018	BUY	$88.96 - $104.92 $512,676 - $604,653	5,763 New	5,763 $0
Q2 2018 Jul 19, 2018	SELL	$88.96 - $104.92 $534,204 - $630,044	-6,005 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$89.56 - $137.45 $8,239 - $12,645	-92 Reduced 1.51%	6,005 $0
Q4 2017 Jan 29, 2018	BUY	$127.48 - $144.58 $766,409 - $869,214	6,012 Added 7072.94%	6,097 $0
Q3 2017 Oct 18, 2017	BUY	$109.36 - $136.31 $9,295 - $11,586	85	85 $0

Others Institutions Holding ALB

# of Institutions

927

Shares Held

104M

Call Options Held

8.36M

Put Options Held

14.3M

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $10.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account